跳至主要内容
临床试验/CTRI/2025/08/093176
CTRI/2025/08/093176尚未招募2/3 期

A randomised controlled clinical trial to study efficacy of gokshurguggulu vati with tablet metformin in the management of madhumeha with special reference to hyperglycaemia in diabetes mellitus type 2

Dr Swapnali Dattatray Talap1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月22日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Gokshurguggulu vati is significantly

研究概览

简要总结

The study is a randomized controlled clinical trial to study efficacy of gokshurguggulu vati with tablet metformin in the management of madhumeha with special reference to hyperglycemia in diabetes mellitus type 2 . Study will be carried out at the OPD of kayachikitsa

department of Late Kedari Redekar Ayurvedic Mahavidyalaya and hospital Gadhinglaj Kolhapur. The observation would be drawn on the basis of relief of symptoms after treatment given.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • History of Diabetes mellitus less than 3 years.
  • Patients presenting with Prakarsha mutrata(Increased frequency of urination)Prabhut mutrata(polyuria)Aavila mutrata(Turbid urine).
  • Random blood sugar level should be below 300 mg/dl fasting blood sugar level below 200 mg/dl post prandial sugar level below 300 mg/dl.

排除标准

  • lusion criteria:-
  • Patients of Diabetes Mellitus Type-1
  • Patients having history of raised Blood Sugar Level more than 3 years .
  • Patients of Diabetes Mellitus Type-2 other than Hyperglycemia.
  • Patient will be excluded below age 39 years and above 71 years old.
  • Macrovascular (CAD,PVD,CVD) diseases.
  • Patients having complications like Diabetic ketoacidosis, Retinopathy, Neuropathy,Nephropathy, Gangrene, etc.
  • Juvenile Diabetes Mellitus, Diabetes insipidus.
  • Patients suffering from congenital, chronic systemic illness, Chemotherapy and radiation therapy of CA patients.
  • Surgical and traumatically injured patients.
  • Patient who will discontinue the treatment.
  • Patient unwilling to take the treatment during study.
  • Patient shows any type of adverse effect.
  • Patient who do not attend follow ups regularly.

结局指标

主要结局

Gokshurguggulu vati is significantly

时间窗: Initial assessment at 0 day | Follow up 7th 14th 21st and 30th day | Final assessment at 30th day

effective in Madhumeha

时间窗: Initial assessment at 0 day | Follow up 7th 14th 21st and 30th day | Final assessment at 30th day

次要结局

  • Gokshurguggulu vati is not significantly effective(in Madhumeha As compared to tab Metformin 500 mg)

研究者

发起方
Dr Swapnali Dattatray Talap
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Swapnali Dattatray Talap

Late kedari redekar ayurvedic mahavidyalaya gadhinglaj kolhapur

研究点 (1)

Loading locations...

相似试验

Efficacy of gokshurguggulu vati in the management of... | 临床试验